Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World

As part of the Strafford Publications’ webinar series, Finnegan attorneys Mark Feldstein, Cora Holt, Tom Irving, and Kyu Kim will join a panel discussion on the Federal Circuit’s recent GSK v. Teva decision, and other relevant post-launch non-Hatch Waxman pharmaceutical litigations. The panel will also discuss strategies regarding claim language and label language, as well as types of evidence to adduce to prove inducement of infringement. For more information, or to register, please see Strafford’s website.